factual

Cancer drug cost-per-QALY can approach or exceed $1 million

Because cancer drugs offer marginal benefits in ideal settings while costing enormous amounts, cost-per-quality-adjusted-life-year figures reach stratospheric levels—around $900,000 for some colon cancer drugs and effectively infinite for drugs like Aflibercept that cost more than alternatives while delivering nothing more—far above the $60-70k UK ceiling or the $200-250k upper limit some US economists endorse.

factualpending

Speaker

Vinay Prasad

Evidence Quote

“We see some drugs that may even be infinite, because they cost more than alternatives and they deliver nothing more, such as Aflibercept in colon cancer.”

Source

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant— EconTalk
Created: 6/13/2026, 12:28:36 AM

Your notes

Loading notes...